A new ELISA for use in a 3-ELISA system to assess concentrations of VEGF splice variants and VEGF110 in ovarian cancer tumors

Clinical Chemistry

Volumn 54, Issue 3, 2008, Pages 597-601

  Gutierrez, Johnny ^a   Konecny, Gottfried E ^b   Hong, Kyu ^a   Burges, Alexander ^c   Henry, Timothy D ^d   Lambiase, Pier D ^e   Wai, Lee Wong ^a   Meng, Y Gloria ^a  

^a GENENTECH INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d HENNEPIN COUNTY MEDICAL CENTER   (United States)

^e ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 110; VASCULOTROPIN 121; VASCULOTROPIN 165;

ARTICLE; CELL LYSATE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; OVARY CANCER; PROTEIN ANALYSIS; PROTEIN DETERMINATION; TISSUE LEVEL;

ALTERNATIVE SPLICING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; OVARIAN NEOPLASMS; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 40449120260     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.096099     Document Type: Article

References (20)